Araki H, Hotokebuchi N, Ohta T, Sakaino N, Nishi K
Clin Ther. 1986;8(2):196-202.
The effects of diltiazem on atrioventricular conduction were evaluated in 20 healthy young men. PR intervals of surface ECG were used as markers of atrioventricular conduction. Two hours after the oral administration of 60 mg of diltiazem, the PR interval was prolonged by 30 msec or more (range, 30 to 160 msec) in four subjects, all of whom had long PR intervals (200 to 230 msec) before receiving diltiazem. Changes in the axis of the P wave suggesting the shift of pacemaker from sinus to atrium were observed in one subject, who was excluded from the analysis of PR intervals. The remaining 15 subjects showed no statistically significant changes in PR intervals. None of these 15 subjects had abnormally prolonged PR intervals before taking diltiazem. A significant correlation between PR interval at baseline and the degree of its prolongation by diltiazem was observed. Plasma concentrations of diltiazem ranged from 16.3 to 80.5 ng/ml (mean +/- SD, 29.7 +/- 14.2 ng/ml) two hours after drug administration and did not correlate with changes in PR intervals. The heart rate did not change after diltiazem administration, even in five subjects with sinus bradycardia. We conclude that diltiazem may delay atrioventricular conduction in healthy young adults with long PR intervals.
在20名健康年轻男性中评估了地尔硫䓬对房室传导的影响。体表心电图的PR间期用作房室传导的标志物。口服60毫克地尔硫䓬两小时后,4名受试者的PR间期延长了30毫秒或更多(范围为30至160毫秒),所有这些受试者在接受地尔硫䓬之前PR间期就较长(200至230毫秒)。在1名受试者中观察到P波电轴变化,提示起搏器从窦房结转移至心房,该受试者被排除在PR间期分析之外。其余15名受试者的PR间期无统计学显著变化。这15名受试者在服用地尔硫䓬之前均无PR间期异常延长的情况。观察到基线PR间期与地尔硫䓬使其延长的程度之间存在显著相关性。给药两小时后,地尔硫䓬的血浆浓度范围为16.3至80.5纳克/毫升(平均值±标准差,29.7±14.2纳克/毫升),且与PR间期变化无关。即使在5名窦性心动过缓的受试者中,服用地尔硫䓬后心率也未改变。我们得出结论,地尔硫䓬可能会延迟PR间期较长的健康年轻成年人的房室传导。